- U of Connecticut dental school reappoints dean for 2nd term
- Michigan dentist charged with Medicaid fraud
- House Republicans urge FBI to act against hospital hackers
- Hospital CEO turnover rises 32% year over year: 6 things to know
- ‘Impossible to survive in a silo’: How a surgical group has stayed independent for 50 years
- University Hospitals launches innovation program for startups
- OSF HealthCare’s rural recruitment pitch: Come home
- The EHR isn’t Alexa or Siri — yet
- 70% of staff are housing-insecure: How 1 hospital is protecting its workforce
- Where 3 certificate-of-need laws stand
- 567 top hospitals for nurse communication
- Teladoc joins Walmart virtual care platform
- The FTC’s new healthcare playbook: What hospital leaders should know
- What’s fueling optimism for dentistry’s future
- 14 health plan C-suite exits in 2026
- Palomar Health’s outpatient arm experiences data incident
- American Academy of Pediatric Dentistry installs new president, officers
- Ochsner Health adds GI physician
- How an independent ASC convinced Anthem and UnitedHealthcare to disrupt surgical pricing
- Phase 1 Equity adds multilocation practice in Texas
- 4 key stats on the oral surgeon workforce
- Privia Health inks deal with another independent practice
- Dr. Emile Rossouw appointed president of the American Board of Orthodontics
- Meet the physician named head of Amazon Health Services
- Clinic owner sentenced for $52M fraud scheme
- Acadia in the headlines: 6 things to know
- 26 behavioral health executive moves to know
- Duke Health moves forward with GI center after years-long delay
- 6 trends reshaping DSO activity
- Former Florida dental practice employee accused of destroying documents
- The 5 biggest ASC price tags in 2026
- Specialty dentist pay by state, adjusted for cost of living
- AstraZeneca gains 2nd bladder cancer nod in key expansion for Imfinzi
- Behavioral health hospital operator to pay $32M in Medicare fraud settlement
- Bangladesh Measles Surge Kills 500+ Children; Vaccine Delays Blamed
- Care navigation startup Garner Health banks $100M series E at $2.74B valuation
- HCA bolsters workforce pipeline with healthcare professional college acquisition
- Plant-Based Diet May Cut Obesity Risk For Women In Menopause
- Pharma leaders meet with PM Takaichi in push for Japan to retain R&D edge
- Penn Medicine, K Health partner to deploy AI clinical agents
- CVS restores coverage of Eli Lilly obesity med Zepbound, adds new pill Foundayo
- CVS restores coverage of Eli Lilly obesity med Zepbound, adds new pill Foundayo
- CMS finalizes changes to No Surprises Act dispute resolution process
- Smartwatch App Accurately Detects Major Epileptic Seizures
- Racial Gap Exists For Asthma Inhaler Use
- New Colon Cancer Screening Guidelines Add Blood And At-Home Tests
- CVS expands partnership with Salesforce for greater call center personalization
- Nurse Convicted In Patient's Death Turns Fatal Drug Error Into Cautionary Tale
- Wearable Ultrasound Patch Monitors High-Risk Pregnancies In Real Time
- Listen to the Latest ‘KFF Health News Minute’
- In a Vaccine-Skeptical California County, a Potential Playbook To Contain Measles
- Teladoc Health inks partnership with Walmart to expand virtual care services
- PharmaEssentia taps Incyte alum Eric Vogel as it eyes Besremi expansion
- Kaléo speaks up on allergy awareness to amplify patient stories
- Privacy and PetShops: Remarks at the Regulatory PETshop Series: Cryptographic Technologies and Financial Services Regulation
- NYC Health + Hospitals adds 2nd behavioral health housing site
- Mindfulness isn’t a perk anymore — it’s a workforce strategy
- ‘Standardize what protects the patient’: The balancing act in behavioral healthcare operations
- With Elahere building steam, AbbVie nets FDA nod for another ImmunoGen cancer asset
- Nebraska behavioral health workforce grew 49% since 2010: 4 notes
- Hospitals again ask FTC, DOJ for exemption from expanded premerger notification filings
- Coalition for Health AI unveils governance playbooks for responsible AI adoption
- 10 behavioral healthcare M&A deals in 2026
- Maryland psychiatric hospitals strained at 95% capacity: 5 things to know
- Amazon taps Roy Schoenberg to lead healthcare business as Neil Lindsay plans to step down
- Viridian, awaiting FDA decision, taps WuXi Bio in eye drug supply deal
- U.S. To Keep Ebola-Exposed Citizens In Kenya Under New Policy
- FDA clears 1st neuromodulation device for PTSD
- CAT on a Hot Tin Roof
- GLP-1 Meds May Help Slow the Spread of Certain Obesity-Related Cancers
- GoodRx launches subscription program for low-cost generic medications, telehealth services
- George Washington University locks deal to hand off debt-ridden physician practice to UHS
- Humana invests $83M in new Florida pharmacy distribution center
- As J&J separates from its orthopedics business, it's laying off 56 employees in New Jersey
- ASCO preview: With expectations jacked up, Akeso's ivonescimab to face scrutiny in high-stakes plenary
- An insider’s look at LillyDirect
- GLP-1 manufacturer CordenPharma strikes deal for peptide CDMO, lining up new production sites in US and China
- Weight-Loss Program Helps Women Battling Breast Cancer
- Younger U.S. Women of Color Face Rising Breast Cancer Deaths
- High Fitness Doesn’t Raise A-fib Risk In Young Men, Study Finds
- Cheaper, Alternative Health Plans Are Having A Moment, But Critics Urge Caution
- Ultrafine Wildfire Smoke Particles May Pose Serious Health Risks
- Readers Address Drugged Driving, Suicide Prevention, Worker Shortages
- Montana Hurries To Adopt Trump’s Medicaid Work Rules Amid Budget Woes
- Nurse Convicted in Patient’s Death Turns Fatal Drug Error Into a Cautionary Tale
- Amid policy and pricing headwinds, US healthcare and life sci faces 'vast field of opportunity': survey
- Amid policy and pricing headwinds, US healthcare and life sci faces 'vast field of opportunity': survey
- Biogen investigated by Italian regulator over multiple sclerosis ‘market abuse’ claims
- FDA delays ruling on AstraZeneca’s breast cancer drug after negative adcomm vote
- Eli Lilly wins argument over Noom’s GLP-1 dosing claims
- Remarks at the Stanford Rock Center for Corporate Governance
- Smart ring maker Oura files confidentially for IPO as consumer demand propels revenue growth
- Outlook moves toward potential US nod for thrice-snubbed eye drug with FDA appeal win
- JD Power: Cost pressures worsen member experience with commercial plans
- Trinity Health credits pay rates, cost management for its steady 1% operating margin
- Trump Admin Bars Key U.S. Researchers From Global Virus Response Talk
- Listen to the Latest ‘KFF Health News Minute’
- CVS sues to challenge Tennessee's new PBM law
- As calls for COINS Act expansion grow, will new rules sweep up China biotech licensing?
- Radiopharmaceutical outfit Lantheus mulls potential $7B takeover by Curium: Bloomberg
- Everyone Has A Family Doc, But Can You Get An Appointment?
- Many U.S. College Students With Psychosis Are Not Receiving Treatment
- Antibiotics Won't Help Ease Asthma-Linked Wheezing in Kids
- Yoga Eases Insomnia And Anxiety In Cancer Survivors, Study Finds
- SK bioscience links up with Colombia to enable local production of varicella vaccine
- After prior FDA manufacturing snub, Gilead's hepatitis D med Hepcludex nabs US nod
- Dust Yields Clues to Viral Outbreaks, Study Finds
- 3 Medical Routines That Older People May Not Need
- Cheaper, Alternative Health Plans Are Having a Moment, but Critics Urge Caution
- Acadia boosts ‘More To Parkinson's’ campaign with Ryan Reynolds, Parkinson’s voices
- Niowave kicks off construction of $75M radiopharmaceutical isotope plant in Michigan
- Wheel, b.well partner to build turnkey infrastructure behind AI-native virtual care
- Journalists Distill News on Ebola, Licensing Midwives, and California’s Budget
- Trump Bought Stock in Eli Lilly as His Policies Gave the Drugmaker a Big Boost, Documents Show
- Acting NIAID Chief Steps Down Amid Ebola, Hantavirus Concerns
- Sunscreen Confusion Puts More Americans At Risk For Melanoma
- ACAP warns final ACA rule adds further uncertainty to a market in flux
- Swoop acquires prescription fulfillment platform Nimble to support independent pharmacies
- 1 In 10 U.S. Surgeons Quit Practice, Study Warns Of Shortage
- Video Game Can Detect Depression In Minutes, Study Says
- Quitting Smoking Might Lower Your Dementia Risk
- Severe Asthma Often Comes With Other Serious Health Problems
- Efforts To Understand The Nation's Drugged Driving Problem Stall Under Trump
- 3 Medical Routines That Older People May Not Need
- RFK Jr. Fires Two Leaders Of Major U.S. Health Task Force
- Common Food Preservatives Linked to Major Heart Problems
- Migraine With Aura Linked To Middle-Age Stroke Risk
- Nicotine Vapes Triple Smokers' Odds Of Quitting Tobacco
- Fatty Liver Disease Increases Heart Attack Risk, Study Says
- Religious Anti-Abortion Center Finds Opportunity In Town Without OB-GYNs
- CPAP Insurance Rules Too Stringent, Deny Device Coverage To Sleep Apnea Patients Who Would Benefit
- Fixing Eligibility at the Point of Care: The Missing Link in Medical Device Reimbursement Integrity
- Fixing Eligibility at the Point of Care: The Missing Link in Medical Device Reimbursement Integrity
- The failure of the ‘usual suspects’ approach to life science recruitment
- The failure of the ‘usual suspects’ approach to life science recruitment
- Statement on Novel Exchange-Traded Funds (ETFs)
- Value, Focus, and the Future of MedTech: M&A and Divestitures are Rewriting the Strategic Playbook.
- Value, Focus, and the Future of MedTech: M&A and Divestitures are Rewriting the Strategic Playbook.
- Rollback of PFAS Drinking Water Standards Raises Safety Fears
- Designing an agentic, future‑ready tech roadmap for emerging pharma
- The Boston Children’s Experience: Hidden ICU Risk and AI-Driven De-escalation
- The Boston Children’s Experience: Hidden ICU Risk and AI-Driven De-escalation
- How specialty practices can get more out of technology investments
- Artivion Completes Endospan Acquisition, Expands Aortic Arch Portfolio With FDA-Approved NEXUS System
- Artivion Completes Endospan Acquisition, Expands Aortic Arch Portfolio With FDA-Approved NEXUS System
- Your Handwriting Could Be a Window Into Your Aging Brain
- Real-World Evidence in the AI Era: What You Can Unlock Depends on What You Build On
- How Do Caffeine, Alcohol, Weed, Nicotine Affect MS Symptoms?
- Once-A-Day Pill Effective In Treating Sleep Apnea Without CPAP, Clinical Trial Says
- Teens Turning To Creatine, Not Steroids, For 'Looksmaxxing'
A 7.1% increase tracks the actual rate of inflation, rather than the goal seeked Bureau of Labor Statistics BS CPI:
Michigan Small Business Health Plans Will Cost 7.1% More on Average for 2024
October 26, 2023Michigan small businesses will pay an average of 7.1% more for their employees’ health coverage in 2024, under rate proposals approved by state regulators.
The statewide average increase affects 12 insurance companies that participate in Michigan’s small group market for employers with 50 or fewer employees.
The rate increases approved by the Michigan Department of Insurance and Financial Services range from a low of 4.5 percent for Paramount Insurance Co., which has about 100 people enrolled in small business group policies, to a high 12.1% for Alliance Health and Life Insurance. Co., a subsidiary of Detroit-based Health Alliance Plan, which sells PPO policies and has nearly 20,000 enrollees.
Blue Cross Blue Shield of Michigan, the state’s small group market leader with 170,000 enrollees, received regulatory approval for a 6.7 percent rate increase. Regulators approved a 5.8% rate increase for HMO subsidiary Blue Care Network, which has more than 111,000 enrollees.
Grand Rapids-based Priority Health's small group rates will increase an average of 6.7% for HMO and point-of-service plans. Prices for PPO plans sold by Priority Health Insurance Co. will increase by an average of 6.3%.
Blue Cross Blue Shield and Priority Heath control much of the West Michigan market for small employer health coverage.
When the companies submitted their rate plans to the state in May, representatives from both insurers said claims were trending upward, particularly for prescription drugs, driving up premiums. They specifically noted that the growth of expensive specialty drugs contributed to their pricing proposals.
At Blue Cross Blue Shield, pharmacy claims trended up 12% in 2022 and were 20% higher through the start of 2023, which is significantly higher than we’ve seen in the past , said Sandy Fester, vice president of Michigan affairs at Blue Cross Blue Shield. Fears Grand Rapids Business at the time.
There’s always volatility in (claims) trends, but this year it’s more specific to pharmacy, Fester said in a previous report. This is something that we’re going to see continue to emerge. This is by no means something that is done all at once. They are certainly contributing to the upward trend of these new and emerging therapies that are very expensive.
State regulators approved small-group rate plans largely as insurers offered them in the spring. The only exception was the Health Alliance Plan, where a proposed increase of 12.8% was reduced to an approved 11.1%, according to a summary of rate proposals that the Department of Insurance and Financial Services presented. put online this week.
The Department of Insurance and Financial Services also approved 2024 rates for individual health policies which are on average 5.5% higher than this year’s rates. They include an average increase of 5.2% for individual Priority Health plans.
Regulators approved an average increase of 4% for individual Blue Cross Blue Shield plans and 5.4% for Blue Care Network.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.















